Clinical trials: Malaria Vaccines

Malaria

Efficacy of RTS,S/AS01 Vaccine Against Episodes of Malaria Due to P. Falciparum Infection in Children.

• Completed
• Age: 5 to 17 months
• Phase 2
• Vaccines
• Results posted

This phase IIb trial is being done to find out if the RTS,S/AS01 vaccine helps to prevent children from falling ill with malaria and to evaluate vaccine safety.

Trial name

NCT00380393

Testing

GSK malaria vaccine 257049 Vaccine, Sanofi-Pasteur's Human Diploid Cell Rabies Vaccine

Where

2 sites in Kenya, Tanzania

Volunteers

894 people, healthy volunteers welcome

Sponsor

GlaxoSmithKline